Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Researchers identify safety concerns with neuroblastoma candidate drug

Researchers identify safety concerns with neuroblastoma candidate drug

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Research may lead to breakthroughs in combating cancer drug resistances

Research may lead to breakthroughs in combating cancer drug resistances

Antiviral activity of wheat germ Agglutinin against SARS-CoV-2

Antiviral activity of wheat germ Agglutinin against SARS-CoV-2

Novel small-molecule therapy shows promise against deadly pediatric leukemia

Novel small-molecule therapy shows promise against deadly pediatric leukemia

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

New study clears a pharmacologic hurdle in developing molecularly targeted therapies for AML

New study clears a pharmacologic hurdle in developing molecularly targeted therapies for AML

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

RNF5 protein plays an unusual role in acute myeloid leukemia, study shows

RNF5 protein plays an unusual role in acute myeloid leukemia, study shows

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

CIRM approves a trio of awards for new stem cell-based projects

CIRM approves a trio of awards for new stem cell-based projects

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

New study offers insight into how high-risk form of blood cancer can develop in children

New study offers insight into how high-risk form of blood cancer can develop in children

Scientists identify new therapeutic target for several aggressive cancers

Scientists identify new therapeutic target for several aggressive cancers

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Researchers unravel mechanisms that produce individualized metabolism in leukemia